Emergent Ventures funds ambitious independent researchers with novel ideas. Real evidence: CCT model (pre-registered, Bayesian-validated), TOPOLOGIX's ESM-2 drug-resistance pivot (AUROC 0.804 on Platinum), neurocascade, and ergofluids. Funding range (\K-K typically) sits below her stated floor (K-K), though larger grants occur for exceptional cases.